Home > News > My Top Four Emerging Micro-Cap Biotech Stocks
November 19th, 2007
My Top Four Emerging Micro-Cap Biotech Stocks
Abstract:
BioSante Pharma (BPAX) recently began trading on the Nasdaq under a new ticker in early November and the Company has recently achieved clarity from the FDA on the clinical development requirements for its low-dose testosterone transdermal gel treatment candidate for female sexual dysfunction called LibiGel. BioSante expects to launch a Phase 3 safety trial before year-end and also plans to conduct a second Phase 3 efficacy trial in early 2008. The cardiovascular safety study will involve 2,400 to 3,100 women with one year results sufficient to support a NDA filing (with a four year follow-up also required) for LibiGel along with the two Phase 3 efficacy studies, which will be shorter in duration and involve fewer women. Other recent events include the acquisition of Bradley Pharma (BDY) by privately held Nycomed. Bradley currently markets BioSante's lowest-approved dose transdermal estradiol gel for the treatment of hot flashes and the Nycomed acquisition could boost sales of Elestrin as part of a bigger company with a larger marketing budget. Finally, BioSante anticipates a licensing deal by year-end for its CaP nanotechnology in the area of cosmetic medicine as a dermal filler for the treatment of wrinkles and other applications.
Source:
seekingalpha.com
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024
Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||